Tohru Takeuchi

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Breast Cancer Risk Factors According to Combined Estrogen and Progesterone Receptor Status: A Case-Control Analysis

Keun‐Young Yoo, Kazuo Tajima, S. Miura et al. · American Journal of Epidemiology · 1997 · 101 citations · Full text

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients

Youhei Fujiki, Takuya Kotani, Kentaro Isoda et al. · Modern Rheumatology · 2017 · 96 citations

Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.

Takuya Kotani, Shigeki Makino, Tohru Takeuchi et al. · PubMed · 2008 · 87 citations

Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients

Shuzo Yoshida, Tohru Takeuchi, Takuya Kotani et al. · Journal of Human Hypertension · 2013 · 84 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13